Key result
Type 2 myocardial infarction and myocardial injury were associated with similar all-cause mortality compared to type 1 myocardial infarction over a median 1.8 years.
Why the study?
Does all-cause mortality differ between patients with type 2 MI or myocardial injury compared to type 1 MI?
Cohort (n=458)
No
Does all-cause mortality differ between patients with type 2 MI or myocardial injury compared to type 1 MI?
Patients with type 2 MI and myocardial injury have similar all-cause mortality to those with type 1 MI but are significantly less likely to receive guideline-directed medical therapy for CAD.
Answers are grounded in this paper and cite their sources.
Similar mortality across subtypes supports uniform post-discharge monitoring; extends classification utility beyond observational cohorts.
BACKGROUND: Type 2 myocardial infarction (MI) is defined by a rise and fall of cardiac biomarkers and evidence of ischemia without unstable coronary artery disease (CAD) because of a mismatch in myocardial oxygen supply and demand. Myocardial injury is similar but does not fulfill the clinical criteria for MI. There is uncertainty in terms of the clinical characteristics, management, and outcomes of type 2 MI and myocardial injury in comparison with type 1 MI. PATIENTS AND METHODS: Patients admitted to a Veterans Affairs tertiary care hospital with a rise and fall in cardiac troponin were identified. MI and injury subtypes, presentation, management, and outcomes were determined. RESULTS: Type 1 MI, type 2 MI, and myocardial injury occurred in 137, 146, and 175 patients, respectively. Patients with type 2 MI were older (P=0.02), had lower peak cardiac troponin (P<0.001), and were less likely to receive aspirin and statin at discharge (P<0.001) than type 1 MI survivors. All-cause mortality (median follow-up: 1.8 years) was not different between patient groups (type 1 MI mortality: 29.9%, type 2 MI: 30.8%, myocardial injury: 29.7%; log rank P=0.94). A significant proportion of deaths were attributed to cardiovascular causes in all subgroups (type 1 MI: 34.1%, type 2 MI: 17.8%, myocardial injury: 30.8%). CONCLUSION: Patients with type 2 MI and myocardial injury were less likely to receive medical therapy for CAD than those with type 1 MI. No differences in all-cause mortality among MI subtypes were observed. Additional studies to determine optimal medical therapy and risk stratification strategies for these high-risk populations are warranted.
No takes yet. Share an insight, caveat, or question.
Smilowitz et al. (2017) conducted a cohort in Myocardial Infarction and Myocardial Injury (n=458). Type 2 myocardial infarction or myocardial injury vs. Type 1 myocardial infarction was evaluated on All-cause mortality (p=0.94). Type 2 myocardial infarction and myocardial injury were associated with similar all-cause mortality compared to type 1 myocardial infarction over a median 1.8 years.
Synapse has enriched 10 related papers. Consider them for comparative context: